About us

Top Message

Creating value with the aim of "To be the best reliable API manufacturer".

Since Kyowa Pharma Chemical was established in Takaoka, Toyama Prefecture in 1946, we have been engaged in the manufacture of Active Pharmaceutical Ingredients (APIs), leveraging our proprietary organic synthesis technologies. Today, in addition to APIs, we provide products and services that meet our customers' needs in a wide range of fields, including In Vitro Diagnostics (IVD) and functional cosmetic ingredients.
In August 2025, we commenced full-scale operation of our research pilot plant. The pilot plant has strengthened our capability to provide integrated support from development through commercial production. Through this enhancement, we are able to respond more flexibly and rapidly to the diverse needs of our customers, particularly in the CDMO (Contract Development and Manufacturing Organization) business, which we aim to further expand. It also enables us to broaden opportunities to deliver our products and services to more customers.
In October 2026, Kyowa Pharma Chemical became a member of the Dai Nippon Printing (DNP) Group. By joining the group, we will further enhance the strengths we have cultivated in API development and manufacturing. In addition, through collaboration with other DNP Group companies, we are now able to provide one-stop services ranging from API development to drug product formulation and packaging. By offering optimal solutions tailored to our customers' needs, we will contribute to greater efficiency in drug development, shorter development timelines, and a more robust and reliable supply chain.
We regard helping realize healthier lives and more smiles for people around the world as one of our most important missions. We believe that continuously providing high-quality pharmaceutical products that support patients' lives and health contributes not only to solving social challenges but also to the sustainable growth of our company.
Going forward, we will continue expanding our CDMO business, supporting customers from the early stages of drug development through commercial manufacturing, while further developing our API business through the technologies and expertise we have cultivated over many years. Through these efforts, we strive to realize our vision of becoming one of the leading API manufacturers in Japan -the first-choice partner for customers in Japan and around the world.
We will continue to take on new challenges as it strives to be "the best reliable API manufacturer," trusted by customers, patients, and local communities, to “bring health and smiles to people around the world”.

Company Profile

Company History

Sites